Bond.az White LogoBond.az Black Logo

#cancer

Latest news and interesting information about cancer.

2026-06-14 03:01
|
312

Healthy man treated for cancer for seven years

A healthy UK man received cancer treatment for seven years after a misdiagnosis. Learn about the error and hospital apology.

0
2026-06-13 02:01
|
459

How Many Cups of Tea Per Day Are Beneficial?

How many cups of tea per day are beneficial? Gastroenterologist reveals recommended daily intake, polyphenols, caffeine limits, and effects during pregnancy.

0
2026-06-11 07:32
|
562

41 people diagnosed with cancer daily in Azerbaijan

In 2025, 41 people are diagnosed with cancer daily in Azerbaijan. 15,144 new cases registered.

0
2026-06-10 03:01
|
921

Strength training extends life

Harvard study: Strength training extends life, reduces risk of death.

0
2026-06-09 08:30
|
210

New Brain Cancer Vaccines Await Approval

Russian agency plans to approve two new glioblastoma vaccines by 2026, including peptide and mRNA types.

0
2026-06-05 07:32
|
444

Vagif Samadoghlu: "God, shall I come, or will You send someone?"

Biography of Vagif Samadoghlu, People's Poet of Azerbaijan. His poem "God, shall I come, or will You send someone?"

0
2026-06-02 00:30
|
642

Terrible Bus Accident in Turkey

A passenger bus crash in Turkey kills 8; man saves wife but dies with infant son. Another mother-daughter duo perishes after cancer battle.

0
2026-06-01 06:30
|
730

CRISM Secures £99,902 Grant for Cancer

CRISM Therapeutics receives £99,902 grant from Invest NI for docetaxel-ChemoSeed prostate cancer program development.

0
2026-05-31 21:01
|
461

Could GLP-1 drugs be oncology's next big opportunity?

New research suggests GLP-1 drugs may play a role in cancer prevention and treatment, opening a potential new frontier for these popular therapies.

0
2026-05-31 13:01
|
802

Prostate cancer death risk cut by 20% with J&J drug

Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.

0
2026-05-31 12:30
|
354

J&J prostate cancer drug reduces spread and death risk

J&J's Erleada prostate cancer drug reduces risk of spread and death in late-stage study. New data presented at ASCO.

0
2026-05-31 12:04
|
457

Novartis radiopharma drug shows promise

Novartis experimental actinium-based radiopharma drug shows anti-tumor activity in prostate cancer, including in patients previously treated with Pluvicto.

0
2026-05-31 12:01
|
466

Novartis prostate cancer drug shows promise

Novartis experimental actinium-based drug shows promising anti-tumor activity in prostate cancer, significantly reducing PSA levels.

0
2026-05-30 12:02
|
726

Sushi Danger: Diseases from Improper Preparation

Improperly prepared sushi can cause parasitic and infectious diseases. Learn about risk groups, storage conditions, and symptoms.

0
2026-05-29 20:02
|
606

Lyon legend Bergougnoux dies at 43

Bryan Bergougnoux, former Lyon midfielder and three-time French champion, dies at 43 after battle with cancer.

0
2026-05-27 12:34
|
406

Ernexa Advances ERNA-101 Toward Q3 IND Filing

Ernexa Therapeutics advances ERNA-101 toward Q3 IND filing. The company has completed process development and moved to GMP manufacturing for clinical trials.

0
2026-05-27 12:32
|
478

VolitionRx Q1 Revenue Surges 300%, Nears Vet Milestone

VolitionRx Q1 revenue jumps 300% to $1M. Company nears vet milestone with Nu.Q test. Stock up 18%. Analyst targets $16-$24.

0
2026-05-27 10:31
|
898

Cancer found in ex-US Attorney General

Former US Attorney General Pam Bondi diagnosed with thyroid cancer. She has undergone treatment and is recovering.

0
2026-05-27 09:02
|
855

FP-001 42 mg Clinical Trial Completed

Foresee Pharmaceuticals completes Phase 3 trial for FP-001 42 mg for precocious puberty. FDA submission planned for 2026. CAMCEVI 21mg approved in Europe.

0
2026-05-27 01:32
|
429

Junshi Biosciences completes phase III lung cancer study

Junshi Biosciences completes phase III lung cancer study. Toripalimab combination shows promising results in resectable stage II-III NSCLC.

0
2026-05-27 00:30
|
409

Melanoma: Who is in the risk group?

Melanoma is an aggressive cancer. Who is at risk? Learn about symptoms and prevention.

0
2026-05-26 07:04
|
236

Enhertu Gets EU Panel Backing for HER2+ Tumors

Enhertu receives EU panel backing for HER2-positive solid tumors. If approved, it would be the first tumor agnostic HER2 therapy in the EU.

0
2026-05-26 06:30
|
231

Poolbeg Pharma Gets FDA Feedback on POLB 001

Poolbeg Pharma receives FDA feedback on POLB 001 for cancer immunotherapy-induced Cytokine Release Syndrome.

0
2026-05-26 01:01
|
397

98-year-old fulfills childhood dream: flies on plane wing

98-year-old British woman flies on plane wing, sets Guinness record, and raises funds for children's cancer charity. Her childhood dream came true.

0
2026-05-25 23:30
|
918

Device Detects Cancer from One Drop of Blood

Chinese scientists invent portable device that detects cancer from one drop of blood with 94.9% accuracy, costing only $5 per sensor.

0
2026-05-25 15:02
|
282

Lula starts radiation after early skin cancer

Brazilian President Lula starts preventive radiation after early-stage skin cancer diagnosis.

0
2026-05-25 03:15
|
708

Genetic Link Found Between Cats and Human Cancer

Cats and humans share genetic similarities in cancer, including aggressive breast cancer. 500 feline tumors analyzed.

0
2026-05-23 12:20
|
281

Pfizer SWOT analysis: new drugs

Pfizer SWOT analysis: new drugs Tukysa and anti-obesity strategy to navigate patent cliff.

0
2026-05-23 07:45
|
276

Rob Base dies at 60

Rob Base, rapper of It Takes Two fame, dies at 60 after battle with cancer. The hip-hop community mourns the loss.

0
2026-05-23 04:30
|
338

Man in UK Gets False Cancer Diagnosis for 7 Years

A 41-year-old man in the UK received a false cancer diagnosis for 7 years, enduring painful treatments. He now seeks justice.

0
...